Insider · CIK 0001235637

FOURTEAU PATRICK

Reports to the SEC for 3 companies · CHANDLER, AZ

sec.gov

Transactions

Companies

Filings

CIK

0001235637

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-01-31	REPROS THERAPEUTICS INC.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2018-01-31	REPROS THERAPEUTICS INC.D Disposition to Issuer	Director	DDisposition to Issuer	−27.8K sh	$0.67	−$18.6K	0
2018-01-29	REPROS THERAPEUTICS INC.U Disposition from Tender	Director	UDisposition from Tender	−12.2K sh	$0.67	−$8,188.07	27,779
2017-09-15	REPROS THERAPEUTICS INC.Stock OptionA Award	Director	AAward	+5,000 sh	—	—	5,000
2017-08-04	Insys Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$1.62	+$16.2K	69,682
2017-08-04	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	63,770
2017-05-26	Insys Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$3.63	+$36.3K	59,682
2017-05-26	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	50,000
2017-02-21	Insys Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2017-02-21	Insys Therapeutics, Inc.Restricted Stock UnitsA Award	Director	AAward	+4,000 sh	—	—	4,000
2017-02-13	REPROS THERAPEUTICS INC.A Award	Director	AAward	+40K sh	—	—	40,000
2016-08-11	Insys Therapeutics, Inc.S Sale	Director	SSale	−15K sh	$18.46	−$277K	49,682
2016-06-30	REPROS THERAPEUTICS INC.Stock OptionA Award	Director	AAward	+5,000 sh	—	—	5,000
2016-05-12	REPROS THERAPEUTICS INC.Stock OptionA Award	Director	AAward	+100K sh	—	—	100,000
2016-05-02	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2016-03-04	Insys Therapeutics, Inc.S Sale	Director	SSale	−15K sh	$18.22	−$273K	64,682
2015-11-12	Insys Therapeutics, Inc.S Sale	Director	SSale	−30K sh	$26.48	−$794K	79,682
2015-05-27	Insys Therapeutics, Inc.S Sale	Director	SSale	−1,311 sh	$60.14	−$78.8K	54,841
2015-05-26	Insys Therapeutics, Inc.S Sale	Director	SSale	−4,784 sh	$60.00	−$287K	56,152
2015-05-20	Insys Therapeutics, Inc.S Sale	Director	SSale	−6,095 sh	$60.00	−$366K	60,936
2015-05-19	Insys Therapeutics, Inc.S Sale	Director	SSale	−2,969 sh	$60.00	−$178K	67,031
2015-05-05	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2015-03-11	Insys Therapeutics, Inc.S Sale	Director	SSale	−10K sh	$59.94	−$599K	70,000
2014-11-19	Insys Therapeutics, Inc.S Sale	Director	SSale	−25K sh	$39.11	−$978K	80,000
2014-08-07	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2013-08-14	Insys Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$23.77	+$119K	65,000
2013-05-14	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2013-05-14	Insys Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$10.90	+$54.5K	60,000
2013-05-13	Insys Therapeutics, Inc.P Purchase	Director	PPurchase	+2,000 sh	$11.10	+$22.2K	55,000
2013-05-09	Insys Therapeutics, Inc.P Purchase	Director	PPurchase	+2,800 sh	$10.75	+$30.1K	53,000
2013-05-08	Insys Therapeutics, Inc.P Purchase	Director	PPurchase	+200 sh	$10.40	+$2,080	50,200
2013-05-07	Insys Therapeutics, Inc.P Purchase	Director	PPurchase	+12.5K sh	$9.45	+$118K	50,000
2013-05-07	Insys Therapeutics, Inc.P Purchase	Director	PPurchase	+37.5K sh	$8.00	+$300K	37,500
2008-05-15	SCIELE PHARMA, INC.Common Stock OptionsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−50K sh	—	—	325,000
2008-05-15	SCIELE PHARMA, INC.S Sale	Director, Chief Executive Officer	SSale	−100K sh	$21.08	−$2.11M	498,533
2008-05-15	SCIELE PHARMA, INC.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+100K sh	—	—	598,533
2008-05-15	SCIELE PHARMA, INC.Common Stock OptionsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−50K sh	—	—	275,000
2004-12-10	SCIELE PHARMA, INC.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+200K sh	$23.19	+$4.64M	530,424
2004-12-10	SCIELE PHARMA, INC.Non-Qualified Stock OptionX Exercise of In-Money	Director, Chief Executive Officer	XExercise of In-Money	−47.5K sh	$23.19	−$1.1M	150,000
2004-12-10	SCIELE PHARMA, INC.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−200K sh	$23.19	−$4.64M	330,424
2004-12-10	SCIELE PHARMA, INC.Non-Qualified Stock OptionX Exercise of In-Money	Director, Chief Executive Officer	XExercise of In-Money	−100K sh	$23.19	−$2.32M	0
2004-12-10	SCIELE PHARMA, INC.Non-Qualified Stock OptionX Exercise of In-Money	Director, Chief Executive Officer	XExercise of In-Money	−52.5K sh	$23.19	−$1.22M	167,500
2004-12-10	SCIELE PHARMA, INC.S Sale	Director, Chief Executive Officer	SSale	−200K sh	$23.19	−$4.64M	330,424
2004-12-08	SCIELE PHARMA, INC.5 Year Cliff, Performance Vesting Stock OptionsA Award	Director, Chief Executive Officer	AAward	+100K sh	$21.36	+$2.14M	100,000
2004-08-09	SCIELE PHARMA, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+8,000 sh	$15.72	+$126K	280,424
2003-11-17	SCIELE PHARMA, INC.Stock OptionA Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	200,000
2003-09-15	SCIELE PHARMA, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$7.16	+$35.8K	114,924
2003-09-15	SCIELE PHARMA, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$7.32	+$36.6K	119,924
2003-09-15	SCIELE PHARMA, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$7.00	+$35K	109,924
2003-09-12	SCIELE PHARMA, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$6.95	+$34.8K	104,924

Recent filings

Accepted (ET)
Jan 314
FOURTEAU PATRICK0001144204-18-004787
SEC(opens sec.gov)
Sep 184
FOURTEAU PATRICK0001144204-17-048486
SEC(opens sec.gov)
Aug 44
FOURTEAU PATRICK0001209191-17-047756
SEC(opens sec.gov)
May 264
Insys Therapeutics, Inc.0001209191-17-035824
SEC(opens sec.gov)
Feb 234
Insys Therapeutics, Inc.0001209191-17-014091
SEC(opens sec.gov)
Feb 154
REPROS THERAPEUTICS INC.0001144204-17-009364
SEC(opens sec.gov)
Aug 124
Insys Therapeutics, Inc.0001209191-16-136823
SEC(opens sec.gov)
Jul 54
REPROS THERAPEUTICS INC.0001144204-16-111503
SEC(opens sec.gov)
May 164
REPROS THERAPEUTICS INC.0001144204-16-102638
SEC(opens sec.gov)
May 44
Insys Therapeutics, Inc.0001209191-16-117588
SEC(opens sec.gov)
Mar 44
Insys Therapeutics, Inc.0001209191-16-106146
SEC(opens sec.gov)
Nov 134
Insys Therapeutics, Inc.0001209191-15-080009
SEC(opens sec.gov)
May 274
Insys Therapeutics, Inc.0001209191-15-047219
SEC(opens sec.gov)
May 204
Insys Therapeutics, Inc.0001209191-15-044996
SEC(opens sec.gov)

Companies

Address

C/O INSYS THERAPEUTICS, INC. 444 SOUTH ELLIS STREET

CHANDLER, AZ, 85224